Journal Title：Cell Reports Medicine

Cell Reports Medicine is a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine.

The content published in Cell Reports Medicine reaches a broad range of scientists and clinicians across the spectrum of medical disciplines, ensuring that your work will be both visible and accessible. The journal publishes original research that ranges from exciting concepts in human biology, health, and disease to all phases of clinical work. We encourage submissions featuring innovative ideas that open up new directions in clinical research and practice, as well as studies that provide critical information that enriches our understanding of current standards of care in diagnosis, treatment, and prognosis. This includes, but is not limited to, translational studies, clinical trials in all areas of medicine including long-term trial follow-ups as well as work in genomics, biomarker discovery, and developments in technology that contribute to diagnostics, treatment, and healthcare. Studies based on vertebrate model organisms also fall within the scope of the journal, provided that the results are directly relevant to human health and disease.

Like our sister journal Cell Reports, we will consider impactful, single-point papers called reports, in addition to longer articles. Large datasets, techniques, and tools for the community can also be considered under the article format. We will also publish reviews covering recent literature in emerging and active fields.

The professional in-house scientific editors at Cell Reports Medicine work closely with authors, reviewers, and the journal's editorial board to ensure exemplary editorial process, fair and robust peer review, and rapid dissemination and communication of your research.

Cell Reports Medicine 是 Cell Press 出版的優質開放獲取期刊，發表轉化和臨床生物醫學領域的前沿研究，為人類健康和醫學提供信息和影響。

Cell Reports Medicine 上發表的內容覆蓋了醫學領域各個領域的科學家和臨床醫生，確保您的工作既可見又可訪問。該期刊發表的原創研究范圍從人類生物學、健康和疾病的激動人心的概念到臨床工作的所有階段。我們鼓勵提交具有創新思想的論文，這些思想可以開辟臨床研究和實踐的新方向，以及提供關鍵信息的研究，這些研究可以豐富我們對診斷、治療和預后當前護理標準的理解。這包括但不限于轉化研究、醫學所有領域的臨床試驗（包括長期試驗隨訪）以及基因組學、生物標志物發現和有助于診斷、治療和醫療保健的技術發展方面的工作。基于脊椎動物模型生物的研究也屬于該期刊的范疇，前提是研究結果與人類健康和疾病直接相關。

與我們的姊妹期刊《Cell Reports》一樣，除了較長的文章外，我們還會考慮有影響力的單點論文（稱為報告）。社區的大型數據集、技術和工具也可以在文章格式下考慮。我們還將發表涵蓋新興和活躍領域的最新文獻的評論。

《Cell Reports Medicine》的專業內部科學編輯與作者、審稿人和期刊編輯委員會密切合作，以確保出色的編輯過程、公平而嚴格的同行評審以及快速傳播和交流您的研究。

Cell Reports Medicine創刊于2020年，由Elsevier出版商出版，收稿方向涵蓋Biochemistry, Genetics and Molecular Biology - Biochemistry, Genetics and Molecular Biology (all)全領域，在行業領域中學術影響力很大，屬于TOP期刊，國際一流期刊，關注度和專業度非常高，所以對原創文章要求創新性很高，過審難度很高，如果您有志于TOP期刊，建議關注此刊。平均審稿速度約Time to desk decision: 6.6 days; Publication time: 3.31 weeks 17 Weeks ，影響因子指數11.7，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。